Palliative radiation therapy for high-risk asymptomatic bone metastases significantly prolonged OS while reducing skeletal-related events compared with standard therapy, phase 2 trial results showed.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.